China SXT Pharmaceuticals Inc(SXTC)stock report

*Nasdaq FSI: *Deficient: Issuer Failed to Meet NASDAQ Continued Listing Requirements

China SXT Pharmaceuticals Inc is a pharmaceutical company, which develops traditional Chinese medicine pieces (TCMP). The Company develops and sells three types of TCMPs such as Advanced TCMP, Fine TCMP, and Regular TCMP. The Company sells its TCMP products under three brand names such as Suxuangtang, Hui Chun Tang and Tong Ren Tang. As of December 4, 2017 It had a product portfolio of 13 Advanced TCMP, over 30 Fine TCMP, and 600 Regular TCMP that addresses several of diseases and medical indications.

Finance:
Market Cap:28.8M; Shares Outstanding:26.9M; Short Interest: 1.12%

EPS and Sales:
https://finance.yahoo.com/quote/SXTC/financials?p=SXTC

Date EPS % last year % last quarter
2018.9.30 0.05 25.00% 28.21%
2018.12.31 0.06 0.00% 20.00%
2019.6.30 0.05 28.21% -16.67%
2019.12.31 0.075 27.12% 50.00%

 

Date Sales % last year % last quarter
2018.9.30 5.59M 49.78% 43.70%
2018.12.31 7.02M 43.79% 25.58%
2019.6.30 3.92M 0.72% -44.16%
2019.12.31 7.01M -0.10% 78.83%

 

Insider Transactions:
http://insidercow.com/history/company.jsp?company=SXTC&B1=Search%21

Institution Ownership:
https://www.marketbeat.com/stocks/NYSE/SXTC/institutional-ownership/

2020.01.13:
Total institutions: 9,no change
Shares hold: 2077.3k shares. no change
shares% hold: 7.72%,no change

Analyst Ratings:
https://www.tipranks.com/stocks/SXTC/price-targe

Leave a Reply